Insiders Are Piling Into These 10 Healthcare Stocks in 2024

Yahoo FinanceApr 10 15:30 ET

Greenwich LifeSciences(GLSI.US) 10% Shareholder Buys US$57,240 in Common Stock

$Greenwich LifeSciences(GLSI.US)$ 10% Shareholder Patel Snehal purchased 3,000 shares of Common Stock on Apr 1, 2024 at an average price of $19.08 for a total value of $57,240.Source: Announcement Wha

moomoo NewsApr 3 06:50 ET

Greenwich LifeSciences(GLSI.US) 10% Shareholder Buys US$49,950 in Common Stocks

$Greenwich LifeSciences(GLSI.US)$ 10% Shareholder Patel Snehal purchased 2,500 shares of Common Stocks on Mar 22, 2024 at an average price of $19.98 for a total value of $49,950.Source: Announcement W

moomoo NewsMar 26 06:47 ET

Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view t

BenzingaMar 25 09:00 ET

Greenwich LifeSciences(GLSI.US) 10% Shareholder Buys US$26,520 in Common Stocks

$Greenwich LifeSciences(GLSI.US)$ 10% Shareholder Patel Snehal purchased 1,500 shares of Common Stocks on Mar 20, 2024 at an average price of $17.68 for a total value of $26,520.Source: Announcement W

moomoo NewsMar 22 06:45 ET

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,

GlobeNewswireMar 13 06:00 ET